The Multiple Sclerosis Association of America (MSAA) is pleased to present its latest edition of “What’s New in MS Research.” This series of online articles is published periodically and features important information on topics ranging from highlights of major international MS conferences and updates on trials with experimental disease-modifying therapies, to new findings on the development of the disease, symptom management, and quality-of-life issues.
This latest edition of “What’s New in MS Research” features trial results from recent studies as well as updates on a variety of MS-related issues. Topics include:
- Positive results for the investigational treatment ublituximab
- The importance of identifying anxiety and depression in early MS
- Intriguing results with cannabis for bladder symptoms with MS
- Assistive devices that show the greatest strides
- And many other vital topics
Please read MSAA’s latest edition of "What’s New in MS Research." We hope you find these updates to be both informative and encouraging, providing help and hope to the entire MS community.
For additional information on the latest advancements in MS research, please also see MSAA’s archived educational webinar What’s New in MS Research: A Look Into the Future of Multiple Sclerosis Treatment — July 2021 featuring neurologist Barry Singer, MD.
